Novaminsulfon Tropfen (Metamizole Sodium Monohydrate)

Metamizole Sodium works by inhibiting cyclooxygenase enzymes, which leads to a decrease in prostaglandin synthesis. Lower prostaglandin levels reduce inflammation, pain signaling, and the hypothalamic set‑point for temperature, providing both analgesic and antipyretic effects without engaging opioid receptors.

The specific dose of Novaminsulfon Tropfen is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, and renal or hepatic function. Physicians follow local prescribing guidelines and may adjust the dose according to therapeutic response and tolerability.

Data on metamizole use during pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. Many regulatory agencies recommend caution, and clinicians typically consider alternative analgesics or antipyretics for pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Novaminsulfon Tropfen. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metamizole belongs to the pyrazolone class and offers analgesic and antipyretic effects comparable to NSAIDs such as ibuprofen, but with a different safety profile. Unlike opioids, it does not cause respiratory depression, yet it carries a rare risk of agranulocytosis, a concern less common with standard NSAIDs.

Novaminsulfon Tropfen should be stored at ambient temperature, preferably below 25 °C, in its original container. Protect the solution from moisture, direct sunlight, and extreme temperature fluctuations. Keep the bottle tightly closed when not in use to maintain stability.

The product is administered orally as drops. The prescriber determines the exact volume to be taken, which is measured using a calibrated dropper or oral syringe. Patients should swallow the drops directly or mix them with a small amount of liquid if needed, following the healthcare professional’s instructions.

The most serious adverse reactions associated with metamizole include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe allergic responses such as anaphylaxis or Stevens‑Johnson syndrome. Regular blood‑count monitoring is advised during prolonged therapy to detect early signs of hematologic toxicity.

Novaminsulfon Tropfen is contraindicated in individuals with known hypersensitivity to metamizole or other pyrazolones, patients with existing severe blood dyscrasias, and those with uncontrolled hepatic or renal impairment unless closely supervised. Caution is also advised for patients with a history of asthma or severe allergic reactions.